Redeye: Careium - Careium - A Return to Profitability on the Horizon
9 augusti, 2022
9 augusti, 2022
Redeye updates its estimates following Careium’s Q2’22 report, which was more or less inline with the estimates. Careium continues to execute on its UK restructuring and paving the road for a return to profitability. We also comment on the ARPU opportunity and the software solution that is expected to be commercially launched to external partners in Q3’22.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Careium - A Return to Profitability on the Horizon
9 augusti, 2022
Redeye updates its estimates following Careium’s Q2’22 report, which was more or less inline with the estimates. Careium continues to execute on its UK restructuring and paving the road for a return to profitability. We also comment on the ARPU opportunity and the software solution that is expected to be commercially launched to external partners in Q3’22.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Careium - A Return to Profitability on the Horizon
Swedbank
Rapportperioden
Swedbank
Rapportperioden
1 DAG %
Senast
Cloetta
Igår, 17:42
ABB upp och Essity ned efter rapporter
ISS
Igår, 17:35
Nordea mot strömmen efter rapport
OMX Stockholm 30
1 DAG %
Senast
2 555,63